MX2014007312A - Metodos para el tratamiento y la prevencion de estreñimiento inducido por opioides usando composiciones orales de metilnaltrexona. - Google Patents
Metodos para el tratamiento y la prevencion de estreñimiento inducido por opioides usando composiciones orales de metilnaltrexona.Info
- Publication number
- MX2014007312A MX2014007312A MX2014007312A MX2014007312A MX2014007312A MX 2014007312 A MX2014007312 A MX 2014007312A MX 2014007312 A MX2014007312 A MX 2014007312A MX 2014007312 A MX2014007312 A MX 2014007312A MX 2014007312 A MX2014007312 A MX 2014007312A
- Authority
- MX
- Mexico
- Prior art keywords
- subject
- mntx
- methylnaltrexone
- pharmaceutical composition
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161577654P | 2011-12-19 | 2011-12-19 | |
| PCT/US2012/070612 WO2013096444A1 (en) | 2011-12-19 | 2012-12-19 | Methods for treatment and prevention of opioid induced constipation using oral compositions of methylnaltrexone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2014007312A true MX2014007312A (es) | 2014-08-27 |
Family
ID=48669445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014007312A MX2014007312A (es) | 2011-12-19 | 2012-12-19 | Metodos para el tratamiento y la prevencion de estreñimiento inducido por opioides usando composiciones orales de metilnaltrexona. |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20130317050A1 (enExample) |
| EP (1) | EP2793888A4 (enExample) |
| JP (2) | JP2015501849A (enExample) |
| KR (1) | KR20140107540A (enExample) |
| CN (2) | CN110384701A (enExample) |
| AU (3) | AU2012359013A1 (enExample) |
| BR (1) | BR112014014805A2 (enExample) |
| CA (1) | CA2859203C (enExample) |
| IL (1) | IL233266A0 (enExample) |
| MX (1) | MX2014007312A (enExample) |
| WO (1) | WO2013096444A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI489984B (zh) | 2006-08-04 | 2015-07-01 | Wyeth Corp | 用於非經腸道傳輸化合物之配方及其用途 |
| WO2015191686A1 (en) * | 2014-06-10 | 2015-12-17 | Salix Pharmaceuticals, Inc. | Methods of administering methylnaltrexone |
| EP3206491B1 (en) * | 2014-10-17 | 2019-11-27 | Salix Pharmaceuticals, Inc. | Use of methylnaltrexone to attenuate tumor progression |
| JP2019513355A (ja) * | 2016-03-29 | 2019-05-30 | コロナリーコンセプツ エルエルシー | 便秘症を処置するための製剤 |
| WO2023031955A1 (en) * | 2021-08-28 | 2023-03-09 | Redasani Vijayendrakumar Virendrakumar Ji | Oral pharmaceutical compositions of methylnaltrexone and salt thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS601128A (ja) * | 1983-06-15 | 1985-01-07 | Shionogi & Co Ltd | 作用持続型セフアクロル製剤 |
| US20030158220A1 (en) * | 1997-11-03 | 2003-08-21 | Foss Joseph F. | Use of methylnaltrexone and related compounds to treat chronic opioid use side effects |
| WO2003086415A1 (en) * | 2002-04-05 | 2003-10-23 | Merck & Co., Inc. | Method for inhibiting bone resorption with an alendronate and vitamin d formulation |
| SE0303135D0 (sv) * | 2003-11-25 | 2003-11-25 | Lipocore Holding Ab | Controlled food effect composition |
| EP1906951A4 (en) * | 2005-07-01 | 2009-05-27 | Dynogen Pharmaceuticals Inc | COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL HYPOMOTILITY AND RELEVANT DISEASES |
| CN102014907A (zh) * | 2008-05-07 | 2011-04-13 | 尼克塔治疗公司 | 外周作用阿片拮抗剂的口服给药 |
| CN101845047B (zh) * | 2009-12-31 | 2011-12-07 | 南京臣功制药有限公司 | 一种溴甲基纳曲酮的制备方法 |
| TWI605814B (zh) * | 2010-03-11 | 2017-11-21 | 惠氏有限責任公司 | 甲基拿淬松（ｍｅｔｈｙｌｎａｌｔｒｅｘｏｎｅ）之口服製劑及親脂性鹽 |
-
2012
- 2012-12-19 WO PCT/US2012/070612 patent/WO2013096444A1/en not_active Ceased
- 2012-12-19 EP EP12860187.9A patent/EP2793888A4/en not_active Withdrawn
- 2012-12-19 US US13/720,235 patent/US20130317050A1/en not_active Abandoned
- 2012-12-19 CA CA2859203A patent/CA2859203C/en active Active
- 2012-12-19 MX MX2014007312A patent/MX2014007312A/es unknown
- 2012-12-19 AU AU2012359013A patent/AU2012359013A1/en not_active Abandoned
- 2012-12-19 CN CN201910609611.9A patent/CN110384701A/zh active Pending
- 2012-12-19 KR KR1020147020310A patent/KR20140107540A/ko not_active Ceased
- 2012-12-19 JP JP2014548835A patent/JP2015501849A/ja active Pending
- 2012-12-19 BR BR112014014805A patent/BR112014014805A2/pt not_active Application Discontinuation
- 2012-12-19 CN CN201280070087.9A patent/CN104254332A/zh active Pending
-
2014
- 2014-06-19 IL IL233266A patent/IL233266A0/en unknown
-
2017
- 2017-11-06 AU AU2017258808A patent/AU2017258808A1/en not_active Abandoned
-
2018
- 2018-10-19 JP JP2018197326A patent/JP2019048820A/ja active Pending
- 2018-11-30 US US16/206,570 patent/US20190231771A1/en not_active Abandoned
-
2019
- 2019-05-27 AU AU2019203694A patent/AU2019203694A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL233266A0 (en) | 2014-08-31 |
| CA2859203A1 (en) | 2013-06-27 |
| US20190231771A1 (en) | 2019-08-01 |
| AU2012359013A1 (en) | 2014-06-26 |
| WO2013096444A1 (en) | 2013-06-27 |
| CA2859203C (en) | 2020-08-25 |
| JP2019048820A (ja) | 2019-03-28 |
| EP2793888A4 (en) | 2015-10-28 |
| JP2015501849A (ja) | 2015-01-19 |
| US20130317050A1 (en) | 2013-11-28 |
| CN110384701A (zh) | 2019-10-29 |
| EP2793888A1 (en) | 2014-10-29 |
| BR112014014805A2 (pt) | 2017-06-13 |
| CN104254332A (zh) | 2014-12-31 |
| NZ625863A (en) | 2016-11-25 |
| AU2017258808A1 (en) | 2017-11-23 |
| KR20140107540A (ko) | 2014-09-04 |
| AU2019203694A1 (en) | 2019-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2009201019B2 (en) | Dosage form containing oxycodone and naloxone | |
| US20190231771A1 (en) | Methods for treatment and prevention of opioid induced constipation using oral compositions of methylnaltrexone | |
| TW201141479A (en) | Oral formulations and lipophilic salts of methylnaltrexone | |
| KR20130106431A (ko) | 파킨슨병의 치료에 있어서 오피오이드 효능제와 오피오이드 길항제의 조합물 | |
| TW202308653A (zh) | 以神經活性類固醇進行治療的方法 | |
| NZ625863B2 (en) | Methods for treatment and prevention of opioid induced constipation using oral compositions of methylnaltrexone | |
| WO2015191686A1 (en) | Methods of administering methylnaltrexone | |
| HK1219669A1 (en) | Dosage form containing oxycodone and naloxone | |
| HK1219669B (en) | Dosage form containing oxycodone and naloxone | |
| HK1150754A (en) | Dosage form containing oxycodone and naloxone | |
| HK1168000A (en) | Administration of intravenous ibuprofen | |
| BR102013032395A2 (pt) | Composição farmacêutica oral estável |